Syncom Formulations (India) Ltd. — Board/Management Information 2025

Oct 1, 2025

SYNCOM/SE/2025-26

==> picture [452 x 73] intentionally omitted <==

1[st] October, 2025

Online filing at: www.listing.bseindia.com and https://neaps.nseindia.com/NEWLISTINGCORP/login.jsp

To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Tower, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai (M.H.) 400 001 Mumbai- 400051 BSE CODE:524470 NSE SYMBOL: SYNCOMF

Sub: Disclosure under regulation 30 of the SEBI (LODR) Regulation, 2015 read with sub-clause 7 of Para A of Part A of Schedule: Change in Directorate.

Dear Sir/Madam,

Pursuant to the Regulation 30 of the SEBI(LODR) Regulation, 2015 read with SEBI Master Circular No. SEBI/HO/CFD/CFDPoD2/P/0155 dated 11[th] November 2024, we are pleased to inform that the members of the Company in their 37[th] Annual General Meeting held on Monday, 29[th] September, 2025 at 2:00 P.M. have approved the appointment of Shri Ankit Kedarmal Bankda (DIN: 02359461) as an Director and further Designated as the Chairman and Whole Time Director of the Company, with effect from August 09, 2025.

The additional details as required under Regulation 30 of SEBI (LODR) Regulations, 2015, read with SEBI circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11[th] November, 2024, are enclosed herewith as Annexure-A .

Further, we are also in process of filing the aforesaid Corporate Announcement in the XBRL format within the stipulated time.

Thanking You Yours Faithfully,

For, SYNCOM FORMULATIONS (INDIA) LIMITED

Digitally signed Vaishali by Vaishali Agrawal Agrawal Date: 2025.10.01 17:19:50 +05'30'

CS VAISHALI AGRAWAL COMPANY SECRETARY & COMPLIANCE OFFICER Encl.: Disclosures as above.

==> picture [452 x 73] intentionally omitted <==

==> picture [452 x 73] intentionally omitted <==

Annexure-A DISCLOSURES UNDER REGULATION 30 OF THE SEBI(LODR)REGULATION, 2015 READ WITH SEBI CIRCULAR NO. SEBI/HO/CFD/CFDPOD2/P/0155 DATED 11[TH] NOVEMBER 2024

1. Confirmation of Appointment of Shri Ankit Kedarmal Bankda (DIN: 02359461) as an Director and Designated as the Chairman and Whole Time Director of the Company, with effect from August 09, 2025.

		effect from August 09, 2025.
a		Reason for change viz.appointment~~, re-~~appointment, resignation, removal, deathor otherwise; (tenure completion)	Appointment
b		Date of appointment~~/re-appointment/~~cessation (as applicable) & term ofappointment/re-appointment	Confirmation of the members w.e.f. 29thSept., 2025from the actual date of appointment w.e.f. 9thAugust, 2025.
c		Profile (in case of appointment);	Shri Ankit Kedarmal Bankda is a Post-Graduate inCommerce and a member of the Promoter Group ofthe Company. He possesses over 12 years ofcomprehensive experience across various domainsincluding manufacturing, finance and administrativefunctions.He is actively involved in overseeing the financialoperations at the Corporate Office of the Companyas CFO at Indore and Plant at Pithampur. In view ofhis experience and deep understanding of theCompany’s operations the appointment of ShriAnkit Kedarmal Bankda as Chairman andWholetime Director would be in the best interest ofthe Company.
d		Disclosure of relationships betweendirectors (in case of appointment of adirector).	He is son of Shri Kedarmal Shankarlal Bankda, ExChairman and Whole Time Director of the company.
e		Information as required pursuant to BSECircular with ref. no. LIST/ COMP/14/2018-19 dated 20thJune 2018 andNational Stock Exchange of IndiaLimited Circular no. NSE/CML/2018/02dated June 20, 2018	The Director being appointed is not debarred fromholding the office of director by virtue of any SEBIorder or any other such authority.

For, SYNCOM FORMULATIONS (INDIA) LIMITED

Digitally signed Vaishali by Vaishali Agrawal Agrawal Date: 2025.10.01 17:20:10 +05'30'

CS VAISHALI AGRAWAL COMPANY SECRETARY & COMPLIANCE OFFICER

==> picture [452 x 73] intentionally omitted <==